-+ 0.00%
-+ 0.00%
-+ 0.00%

AXSOME THERAPEUTICS, - DOSES FIRST PATIENT IN SUMMIT PHASE 3 TRIAL OF AXS-05 FOR SMOKING CESSATION

Reuters·08/31/2026 11:01:39

Please log in to view news